Mahadevan, D., Parekh, J., Beck, J. T., McKean, W. B., Schreck, K. C., Olszanski, A. J., Shields, M. D., Phan, V., Hamm, J. T., Bank, B. B., Zhou, J., Chamberlain, M. C., Bhatia, K., Ewesuedo, R. (2026). A first-in-human phase 1a study of LP-184, a tumor site–activated novel alkylating agent, in patients with advanced solid tumors.. Journal of Clinical Oncology. https://doi.org/10.1200/jco.2026.44.16_suppl.e15156